UBE2C anticorps (C-Term)
Aperçu rapide pour UBE2C anticorps (C-Term) (ABIN6243143)
Antigène
Voir toutes UBE2C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Homologie
- B, Pr, M
-
Purification
- This antibody is purified through a protein G column, followed by dialysis against PBS.
-
Immunogène
- This UBE2C antibody is generated from a mouse immunized with a KLH conjugated synthetic peptide between 137~172 amino acids from the C-terminal region of human UBE2C.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- WB: 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- UBE2C (Ubiquitin-Conjugating Enzyme E2C (UBE2C))
-
Autre désignation
- UBE2C
-
Sujet
- Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 11'- and 'Lys-48'-linked polyubiquitination. Acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. Acts by initiating 'Lys-11'-linked polyubiquitin chains on APC/C substrates, leading to the degradation of APC/C substrates by the proteasome and promoting mitotic exit.
-
Poids moléculaire
- 19652
-
UniProt
- O00762
-
Pathways
- Ubiquitin Proteasome Pathway
Antigène
-